Bayesian regression methodology for estimating a receiver operating characteristic curve with two radiologic applications: Prostate biopsy and spiralCT of ureteral stones
Aj. O'Malley et al., Bayesian regression methodology for estimating a receiver operating characteristic curve with two radiologic applications: Prostate biopsy and spiralCT of ureteral stones, ACAD RADIOL, 8(8), 2001, pp. 713-725
Rationale and Objectives. The authors evaluated two Bayesian regression mod
els for receiver operating characteristic (ROC) curve analysis of continuou
s diagnostic outcome data with covariates.
Materials and Methods. Full and partial Bayesian regression models were app
lied to data from two studies (n = 180 and 100, respectively): (a) The diag
nostic value of prostate-specific antigen (PSA) levels (outcome variable) f
or predicting disease after radical prostatectomy (gold standard) was evalu
ated for three risk groups (covariates) based on Gleason scores. (b) Spiral
computed tomography was performed on patients with proved obstructing uret
eral stones. The predictive value of stone size (outcome) was evaluated alo
ng with two treatment options (gold standard), as well as stone location (i
n or not in the ureterovesical junction [UVJ]) and patient age (covariates)
. Summary ROC measures were reported, and various prior distributions of th
e regression coefficients were investigated.
Results. (a) In the PSA example, the ROC areas under the full model were 0.
667, 0.769, and 0.703, respectively, for the low-, intermediate-, and high-
risk groups. Under the partial model, the area beneath the ROC curve was 0.
706. (b) The ROC areas for patients with ureteral stones in the UVJ decreas
ed dramatically with age but otherwise were close to that under the partial
model (ie, 0.774). The prior distribution had greater influence in the sec
ond example.
Conclusion. The diagnostic tests were accurate in both examples. PSA levels
were most accurate for staging prostate cancer among intermediate-risk pat
ients. Stone size was predictive of treatment option for all patients other
than those 40 years or older and with a stone in the UVJ.